Worth Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,027
Closed -$331K 143
2024
Q3
$331K Buy
+1,027
New +$336K 0.18% 93
2023
Q3
Sell
-20
Closed -$4.44K 107
2023
Q2
$4.44K Hold
20
﹤0.01% 367
2023
Q1
$4.83K Sell
20
-8
-29% -$1.96K ﹤0.01% 381
2022
Q4
$7.35K Sell
28
-4
-13% -$1.07K 0.01% 330
2022
Q3
$8K Sell
32
-5,715
-99% -$1.39M 0.01% 294
2022
Q2
$1.4M Buy
5,747
+5,289
+1,155% +$1.3M 0.96% 20
2022
Q1
$112K Buy
+458
New +$105K 0.07% 115

Other funds holding AMGN

Worth Asset Management's AMGN Position: Q4 2024 in Review

Worth Asset Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,027 shares — an estimated $331K sold.

Worth Asset Management first reported a position in AMGN in Q1 2022 and held it in 7 quarters. The position peaked at $1.4M in Q2 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Worth Asset Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Worth Asset Management sold 1,027 Amgen shares in Q4 2024, an estimated $331K.
  • Worth Asset Management first reported a position in Amgen in Q1 2022 and held it in 7 quarters.
  • Worth Asset Management's Amgen position peaked at $1.4M in Q2 2022.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Worth Asset Management's 13F filing for Q4 2024, filed 8 Jan 2025.